Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $246.25 | 6 | 93.6% |
| Education | $16.74 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $122.78 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.05 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $32.38 | 2 | $0 (2023) |
| Ethicon US, LLC | $20.04 | 1 | $0 (2022) |
| PFIZER INC. | $16.74 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.75 | 1 | Boston Scientific Corporation ($13.75) |
| 2023 | $32.38 | 2 | Janssen Biotech, Inc. ($32.38) |
| 2022 | $129.07 | 2 | Boston Scientific Corporation ($109.03) |
| 2019 | $71.05 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($71.05) |
| 2018 | $16.74 | 1 | PFIZER INC. ($16.74) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 09/18/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Immunology | ||||||
| 05/02/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Immunology | ||||||
| 09/01/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $109.03 | General |
| Category: EXALT_ENDO | ||||||
| 05/05/2022 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Wound Closure | ||||||
| 10/22/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $71.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2018 | PFIZER INC. | XELJANZ (Drug) | Education | In-kind items and services | $16.74 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 526 | 531 | $608,661 | $66,637 |
| 2022 | 12 | 600 | 611 | $685,804 | $69,959 |
| 2021 | 12 | 597 | 609 | $639,729 | $70,814 |
| 2020 | 14 | 512 | 530 | $530,051 | $61,148 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 151 | 153 | $220,167 | $29,961 | 13.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 109 | 109 | $151,401 | $10,710 | 7.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 43 | 43 | $46,182 | $7,408 | 16.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 81 | $97,686 | $4,863 | 5.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 34 | $13,430 | $2,903 | 21.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 16 | 16 | $17,200 | $2,760 | 16.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $10,250 | $2,474 | 24.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 25 | 25 | $32,575 | $2,447 | 7.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 34 | $9,452 | $2,148 | 22.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $10,318 | $962.54 | 9.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 138 | 138 | $198,582 | $25,721 | 13.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 129 | 129 | $179,181 | $12,861 | 7.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 116 | 119 | $143,514 | $7,669 | 5.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 36 | 36 | $38,664 | $6,299 | 16.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 32 | 32 | $41,696 | $3,236 | 7.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 34 | $13,430 | $2,696 | 20.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $10,660 | $2,677 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 44 | $12,232 | $2,471 | 20.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $11,824 | $1,925 | 16.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $17,184 | $1,791 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,643 | $1,536 | 23.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $12,194 | $1,076 | 8.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 133 | 133 | $191,603 | $25,863 | 13.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 119 | 119 | $165,084 | $12,866 | 7.8% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 113 | 115 | $137,854 | $7,272 | 5.3% |
About Dr. Gregory Schwartz, MD
Dr. Gregory Schwartz, MD is a Specialist healthcare provider based in Corvallis, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760423289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Schwartz, MD has received a total of $262.99 in payments from pharmaceutical and medical device companies, with $13.75 received in 2024. These payments were reported across 7 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($246.25).
As a Medicare-enrolled provider, Schwartz has provided services to 2,235 Medicare beneficiaries, totaling 2,281 services with total Medicare billing of $268,557. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Corvallis, OR
- Active Since 06/08/2006
- Last Updated 03/21/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1760423289
Products in Payments
- EXALT Model D (Device) $109.03
- XIFAXAN (Drug) $71.05
- STELARA (Biological) $32.38
- STRATAFIX (Device) $20.04
- XELJANZ (Drug) $16.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Corvallis
Ryan Stevens, M.d, M.D
Specialist — Payments: $1,429
Grace Golden, Atc, ATC
Specialist
Mr. Bryan Painter, Atc, ATC
Specialist
Peter Hinckle, Md, MD
Specialist
Mr. Thomas Fregoso, M.s. Atc, M.S. ATC
Specialist
Wendy Shumway, Md, MD
Specialist